Cortisone inhibition of tumor angiogenesis measured by a quantitative colorimetric assay in mice
- 29 Downloads
- 13 Citations
Summary
A simple and quantitative angiogenesis assay was developed. Using this assay, the angiostatic effect of cortisone acetate (CA) on three murine tumors was studied. Tumor cells were inoculated i.d. into the syngeneic or heterogeneic hosts (day 0) and the degree of angiogenesis was quantitated on day 3 by measuring the tumor vascular volumes using an Evan’s blue perfusion technique. CA treatment (250 mg/kg for 3 days) significantly suppressed tumor angiogenesis; however, the degree of angiostatic effect was influenced by the tumor types and by the mouse strain used. MBT-2 bladder cancer angiogenesis was suppressed by 77%–80% of controls in C3H/HeN and C57Bl/6 mice, whereas MBT-2 angiogenesis in BALB/c mice was significantly less suppressed by CA (65% inhibition) as compared with values obtained for C3H mice. B16 melanoma or Line-1 lung-cell carcinoma-induced angiogenesis was suppressed by 57%–66% in their syngeneic or heterogeneic hosts. The combined administration of CA and heparin (Sigma; 1,000 units/ml in drinking water) did not influence the outcomes. The data suggest that host factor(s) and tumor factor(s) influenced the expression of CA angiostatic activity. This colorimetric assay enabled a quantitative estimation of the degree of angiogenesis in mammalian animals.
Keywords
Tumor Angiogenesis Cortisone Murine Tumor Cortisone Acetate Solid Tumor GrowthPreview
Unable to display preview. Download preview PDF.
References
- 1.Bibby MC, Double JA, Loadman PM, Duke CV (1989) Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. J Natl Cancer Inst 81: 216PubMedCrossRefGoogle Scholar
- 2.Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 18: 1182Google Scholar
- 3.Folkman J (1975) Tumor angiogenesis. In: Becker FF (ed) Cancer: a comprehensive treatise. Plenum Press, New York, p 335Google Scholar
- 4.Folkman J, Langer R, Linhardt RJ, Haudenshild C, Taylor S (1983) Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221: 719PubMedCrossRefGoogle Scholar
- 5.Harada M, Takeuchi M, Fukao T, Katagiri K (1971) A simple method for the quantitative extraction of dye extravasated into the skin. J Pharm Pharmacol 23: 218PubMedGoogle Scholar
- 6.Kreisle RA, Ershler WB (1988) Investigation of tumor angiogenesis in an id mouse model: role of host-tumor interactions. J Natl Cancer Inst 80: 849PubMedCrossRefGoogle Scholar
- 7.Lee K, Erturk E, Mayer R, Cockett ATK (1987) Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate. Cancer Res 47: 5021PubMedGoogle Scholar
- 8.Milas L, Hunter N, Basic I (1985) Treatment with cortisone plus heparin or hexuronyl heoaminoglycan sulfates of murine tumors and their lung deposit. Clin Exp Metastasis 3: 247PubMedCrossRefGoogle Scholar
- 9.O’Donell RW, Diana MM, Mudholkar GS, McCune CS (1986) In vivo enhancement of antitumor immunity by interleukin 2-rich lymphokines. Cancer Res 46: 3278Google Scholar
- 10.Penhaligon M, Complejohn RS (1985) Combination heparin plus cortisone treatment of two transplanted tumors in C3H/He mice. J Natl Cancer Inst 74: 869PubMedGoogle Scholar
- 11.Rastinejad F, Polverini PJ, Bouck NP (1989) Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56: 1989CrossRefGoogle Scholar
- 12.Sakamoto N, Tanaka NG, Thogo A, Ogawa H (1986) Heparin plus cortisone acetate inhibit tumor growth by blocking endothelial cell proliferation. Cancer J 1: 55Google Scholar
- 13.Zeich M, Ruggiero M, Pasquali F, Chiarugi VP (1985) Effects of cortisone with and without heparin on angiogenesis induced by prostagrandin E and by S180 cells, and on growth of murine transplantable tumors. Int J Cancer 35: 549CrossRefGoogle Scholar